Christopher Cano

Christopher Cano

Fondatore presso
C2 Strategic LLC
55 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Christopher Cano has founded C2 Strategic LLC in 2011, where he is currently the Managing Partner.
He has held former positions at Noven Pharmaceuticals, Inc., Barrier Therapeutics, Inc., Agile Therapeutics, Inc., Almirall LLC, Nucryst Pharmaceuticals Corp.
(New Jersey), Liberty Medical LLC, TFF Pharmaceuticals, Inc., and Duchesnay USA, Inc. At TFF Pharmaceuticals, Inc., he was the Vice President-Business Development from 2018 to 2020.
Mr. Cano has a graduate degree from Rider University and an undergraduate degree from Villanova University.

Posizioni attive di Christopher Cano

SocietàPosizioneInizio
C2 Strategic LLC
Fondatore 01/01/2011

Precedenti posizioni note di Christopher Cano

SocietàPosizioneFine
TFF PHARMACEUTICALS, INC. Direttore operativo 18/12/2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
AGILE THERAPEUTICS, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Christopher Cano

Formazione di Christopher Cano

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Società collegate

Aziende private11

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Retail Trade

Health Technology

Health Technology

C2 Strategic LLC

  1. Mercati
  2. Insiders
  3. Christopher Cano